Effect of intranasal T-bet plasmid transfer on bronchial alveolar lavage fluid IL-13 and ET-1 in a murine asthmatic model

( views:235, downloads:0 )
Author:
XU Xiao-cai(Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China)
TAN Wei-ping(Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China)
WU Bao-jing(Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China)
MAI Xian-di(Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China)
HUANG Hua-rong(Department of Pediatrics, The Second Affiliated Hospital, Sun Yat-sen University, Guangzhou 510120, China)
Journal Title:
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
Issue:
Volume 17, Issue 02, 2011
DOI:
10.3760/cma.j.issn.1674-1927.2011.02.005
Key Word:
Bronchoalveolar lavage fluid;Asthma;T - bet genes;Interleukin 13;Endothelin 1

Abstract: Objective To investigate the effects of airway T-bet plasmid gene transfer on IL-13 and ET-1 in bronchial alveolar lavage fluid (BALF) of murine asthmatic model. Methods Thirty-two C57BL/6J mice were randomized into four groups (8 mice each):the asthmatic model group (group A) , the normal control group (group B) , the pcDNA3 plasmid group (group C) and the pcDNA3-T-bet group (group D). The mouse asthma model was established by sensitization with intraperitoneal injection of ovalbumin (OVA) and intranasal challenge in all animals except for the group B where normal saline was used instead. At 48 hours before intranasal challenges, the group C was intranasally administered 50 μg pcDNA3 plasmid, and the group D with 50μg pcDNA3-T-bet plasmid.At 48 hours after OVA challenge, BALF was collected for determination of IL-13 and ET-1 levels by immunoblotting and ELISA. Results The levels of IL-13 and ET1 in BALF were significantly elevated in the asthmatic model group compared with the normal control group [(2.32±0.40)ng/L vs (0.38±0.16)ng/L,(40.07±6.52)ng/L vs (l4.16±0.5l)ng/L, both P<0.05), and were lowered in the pcDNA3-T-bet group[(1.16±0.19)ng/L and (23.08±2.59)ng/L, respectively] compared with the asthmatic model group (both P<0.05). Conclusion Intranasal pcDNA3-T-bet plasmid transfer can reduce the levels of IL-13 and ET-1 in BALF of the murine asthmatic model.

  • [1]李伟杰.哮喘的基因治疗.国外医学呼吸系统分册,2000,20:1-3.
  • [2]Gill DR,Davies LA,Pringle IA,et al.The development of gene therapy for diseases of the lung.Cell Mol Life Sci,2004,61:355-368.
  • [3]Gautam A,Waldrep CJ,Densmore CL.Delivery systems for pulmonary gene therapy.Am J Respir Med,2002,1:35-46.
  • [4]檀卫平,麦贤弟,吴葆菁,等.哮喘患儿转录因子T-bet/GATA-3mRNA表达及其与杀伤性T淋巴细胞平衡间的关系.中华儿科杂志,2007,45:284-287.
  • [5]Finotto S,Neurath MF,Glickman JN,et al.Development of spontaneous airway changes consistant with human asthma in mice lacking T-bet.Science,2002,295:336-338.
  • [6]Szabe SJ,Kim ST,Costa GL,et al.A novel transcription factor,T-bet,directs Th1 lineage commitment.Cell,2000,100:655-669.
  • [7]Mullen AC,High FA,Hutchins AS,et al.Role of T-bet in commitment of Tb1 cells before IL-12-dependent selection.Science,2001,292:1907-1910.
  • [8]Hancock A,Armstrong L,Gama R,et al.Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung.Am J Respir Cell Mol Biol,1998,18:60-65.
  • [9]Yanagisawa M,Kurihara H,Kimura S,et al.A nove potent vasoconstrictor peptide produced by vascular endothelial cells.Nature,1998,332:411-415.
  • [10]中华医学会呼吸病学分会哮喘学组.第四届全国支气管哮喘学术会议纪要.中华结核和呼吸杂志,2003,26:175.
  • [11]陈兴无,徐军.内皮素在诱导人气管上皮下成纤维细胞转分化中的作用.中国病理生理杂志,2007,23:1125-1129.
  • [12]檀卫平,麦友刚,黄嘉凌,等.小鼠T-bet基因真核表达载体的构建.广东医学,2005,26:1332-1334.
  • [13]李和权,邵传森,谢强敏.鼠白细胞介素12质粒对小鼠支气管哮喘模型气道炎性反应及细胞因子的影响.中华结核和呼吸杂志,2003,26:354-357.
  • [14]Barnes PJ.Cytokine-directed therapies for the treatment of chronic airway diseases.Cytokine Growth Factor Rev,2003,14:511-522.
  • [15]Leckie MJ.Anti-interleukin-5 monoclonal antibodies:preclinical and clinical evidence in asthma models.Am J Respir Med,2003,2:245-259.
  • [16]Finotto S,Glimcher L,T cell directives for transcripfional regulation in asthma.Springer Semin Immunopathol,2004,25:281-294.
  • [17]Hohler T,Reuss E,Adams P,et al.A genetic basis for IFN-gamma production and T-bet expression in humans.J Immunol,2005,175:5457-5462.
  • [18]Finotto S,Neurath MF,Glickman JN,et al.Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet.Science,2002,295:336-338.
  • [19]Gill DR,Davies LA,Pringle IA,et al.The development of gene therapy for disease of lung.Cell Mol Life Sci,2004,61:355-368.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn